{"id":"blood-transfusion","safety":{"commonSideEffects":[{"rate":null,"effect":"Acute hemolytic transfusion reaction"},{"rate":null,"effect":"Febrile non-hemolytic transfusion reaction"},{"rate":null,"effect":"Allergic reaction"},{"rate":null,"effect":"Transfusion-related acute lung injury (TRALI)"},{"rate":null,"effect":"Iron overload (chronic transfusion)"},{"rate":null,"effect":"Infection transmission (rare with modern screening)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Blood transfusion is a medical procedure that replaces lost or deficient blood components, primarily red blood cells, to restore oxygen delivery to tissues. It is used in acute hemorrhage, severe anemia, or conditions where blood cell production is impaired. The transfused blood provides immediate hemoglobin and hematocrit restoration, improving tissue oxygenation and circulatory stability.","oneSentence":"Blood transfusion restores circulating red blood cells and oxygen-carrying capacity by transferring donor blood or blood components into a recipient's bloodstream.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:28:44.938Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute hemorrhage and blood loss"},{"name":"Severe anemia"},{"name":"Perioperative blood replacement"},{"name":"Chronic transfusion-dependent conditions (e.g., thalassemia, sickle cell disease)"}]},"trialDetails":[{"nctId":"NCT01553214","phase":"PHASE4","title":"Improving White Blood Cell Collection From Healthy Donors","status":"RECRUITING","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2012-12-31","conditions":"Allogeneic Granulocyte Donation","enrollment":1000},{"nctId":"NCT04404881","phase":"PHASE2","title":"Bevacizumab In Hereditary Hemorrhagic Telangiectasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hanny Al-Samkari, MD","startDate":"2020-11-23","conditions":"Hereditary Hemorrhagic Telangiectasia","enrollment":33},{"nctId":"NCT01306019","phase":"PHASE1, PHASE2","title":"Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-09-25","conditions":"X-linked Severe Combined Immunodeficiency (XSCID)","enrollment":40},{"nctId":"NCT05124041","phase":"NA","title":"Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2021-11-15","conditions":"Acute on Chronic Liver Failure, Variceal Hemorrhage, Cirrhosis, Liver","enrollment":262},{"nctId":"NCT02611856","phase":"","title":"Monochorial-diamniotic Pregnancies Complicated With a Twin-to-twin Syndrome","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2007-04-03","conditions":"Twin to Twin Transfusion Syndrome","enrollment":179},{"nctId":"NCT06605144","phase":"PHASE3","title":"Canadian Critical Care Comparative Effectiveness Platform","status":"RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2025-03-23","conditions":"Intensive Care Unit ICU, Vasopressor, Platelet","enrollment":5500},{"nctId":"NCT02858323","phase":"","title":"Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2016-07-27","conditions":"Thrombocytopenia, Platelet Transfusion Refractoriness","enrollment":68},{"nctId":"NCT00023023","phase":"","title":"Study of Transfusion-Transmitted Infections","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2002-01-17","conditions":"Viral Disease, Blood Donation, Transfusion-Transmitted Infections","enrollment":1771},{"nctId":"NCT06692335","phase":"NA","title":"HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-02-06","conditions":"Uterine Fibroids (UF)","enrollment":112},{"nctId":"NCT07494708","phase":"NA","title":"Hemoglobin Drop and Need for Blood Transfusion in Primary Knee Arthroplasty With or Without Drain Insertion","status":"COMPLETED","sponsor":"Shifa International Hospital","startDate":"2025-08-01","conditions":"Knee Osteoarthritis, Rheumatoid Arthritis of the Knee, Post-Traumatic Arthritis of the Knee","enrollment":102},{"nctId":"NCT06170788","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-15","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":614},{"nctId":"NCT00920972","phase":"PHASE1, PHASE2","title":"Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2001-12","conditions":"Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies","enrollment":220},{"nctId":"NCT06676904","phase":"NA","title":"Neonatal Platelet Transfusion Threshold Trial","status":"RECRUITING","sponsor":"NICHD Neonatal Research Network","startDate":"2025-06-13","conditions":"Thrombocytopenia, Neonatal, Platelet Transfusion","enrollment":2433},{"nctId":"NCT05664737","phase":"PHASE2","title":"A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2022-12-09","conditions":"Anemia","enrollment":189},{"nctId":"NCT06609226","phase":"PHASE3","title":"A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2025-01-10","conditions":"Sickle Cell Disease, Thalassemia","enrollment":480},{"nctId":"NCT03910452","phase":"EARLY_PHASE1","title":"Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-10-28","conditions":"Chronic Granulomatous Disease","enrollment":4},{"nctId":"NCT05949684","phase":"PHASE3","title":"ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2023-10-24","conditions":"Myelodysplastic Syndromes","enrollment":360},{"nctId":"NCT07006012","phase":"NA","title":"RGL-305+ Lymphoma + Exploratory Clinical Study","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-04-21","conditions":"Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)","enrollment":12},{"nctId":"NCT05477563","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-08-02","conditions":"Beta-Thalassemia, Thalassemia, Hematologic Diseases","enrollment":26},{"nctId":"NCT07096297","phase":"PHASE2","title":"Luspatercept + Darbepoetin in MDS","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-12-16","conditions":"MDS (Myelodysplastic Syndrome)","enrollment":60},{"nctId":"NCT03889834","phase":"NA","title":"Biological Parameters Changes After Autologous Blood Transfusion of Red Blood Cells (200 ml) in Healthy Volunteers.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-01-25","conditions":"The Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy Volunteers","enrollment":30},{"nctId":"NCT03037164","phase":"PHASE3","title":"INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cerus Corporation","startDate":"2017-05-11","conditions":"Anemia","enrollment":692},{"nctId":"NCT01282021","phase":"","title":"Molecular Immunohematology in Ethiopian Sub-Populations","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2012-11-03","conditions":"Immunohematology","enrollment":95},{"nctId":"NCT04797000","phase":"PHASE2","title":"Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-05-25","conditions":"Myelodysplastic Syndromes","enrollment":36},{"nctId":"NCT06358079","phase":"NA","title":"Re-infusion of Unwashed Shed Blood During Off-pump Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Damascus University","startDate":"2024-03-27","conditions":"Coronary Artery Disease, Blood Transfusion Complication, Cardiovascular Complication","enrollment":50},{"nctId":"NCT07483151","phase":"","title":"Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","enrollment":110},{"nctId":"NCT06916832","phase":"","title":"Evaluation of a Patient Blood Management Protocol Impact on the Transfusion Rate in Delivery Hemorrhage","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2024-12-23","conditions":"Delivery Hemorrhage","enrollment":397},{"nctId":"NCT07480980","phase":"","title":"Association of Micro RNA-155 With Alloimmunization in Transfusion-Dependent Patients","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-07-01","conditions":"Red Cell Alloantibodies, Blood Transfusion-Dependent, Beta Thalassemia","enrollment":100},{"nctId":"NCT06421636","phase":"PHASE2","title":"A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2024-09-30","conditions":"Non-Transfusion Dependent Beta-Thalassemia (NTDT)","enrollment":95},{"nctId":"NCT06517862","phase":"PHASE4","title":"Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia","status":"RECRUITING","sponsor":"Amira Adel Fouly","startDate":"2024-09-01","conditions":"Neonatal Hyperbilirubinemia","enrollment":80},{"nctId":"NCT05889494","phase":"NA","title":"Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2025-03-24","conditions":"Postoperative Hemorrhage, Postoperative Anemia, Postoperative Blood Loss","enrollment":64},{"nctId":"NCT07476183","phase":"PHASE1","title":"Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia","status":"NOT_YET_RECRUITING","sponsor":"Apriligen, Inc.","startDate":"2026-03","conditions":"RPS19 Deficient Diamond-Blackfan Anemia","enrollment":4},{"nctId":"NCT06408597","phase":"NA","title":"Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nazmy Edward Seif","startDate":"2024-05-12","conditions":"Prostate Cancer, Bladder Cancer, Surgery","enrollment":90},{"nctId":"NCT07477392","phase":"NA","title":"Effect of Two Different Fluid Treatment Regimens on Ultrasonographic Upper Airway Measurements","status":"COMPLETED","sponsor":"Bozyaka Training and Research Hospital","startDate":"2023-03-01","conditions":"Goal-directed Fluid Theraphy, Upper Airway Ultrasonography","enrollment":145},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT06747546","phase":"NA","title":"Research on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"Children's Hospital of Fudan University","startDate":"2025-01-01","conditions":"Congenital Heart Disease (CHD), Cardiopulmonary Bypass, Children","enrollment":300},{"nctId":"NCT07475624","phase":"","title":"Determinants of Digestive Morbidity in Neonatal Jaundice","status":"COMPLETED","sponsor":"The First Hospital of Jilin University","startDate":"2019-12-01","conditions":"Digestive","enrollment":3218},{"nctId":"NCT07179276","phase":"NA","title":"Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2026-03-15","conditions":"Sepsis - to Reduce Mortality in the Intensive Care Unit, Septic Shock","enrollment":750},{"nctId":"NCT05189925","phase":"PHASE1","title":"NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-07-22","conditions":"Chronic Granulomatous Disease, Infection","enrollment":25},{"nctId":"NCT06763341","phase":"PHASE1","title":"A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2025-07-30","conditions":"Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia","enrollment":12},{"nctId":"NCT07458178","phase":"","title":"A New Scoring System to Predict High-Risk Groups in Upper Gastrointestinal Bleeding","status":"COMPLETED","sponsor":"Izmir Katip Celebi University","startDate":"2024-01-01","conditions":"Upper Gastrointestinal Bleeding (UGIB), High Risk Bleeding","enrollment":312},{"nctId":"NCT06872333","phase":"PHASE2","title":"Allo HSCT for High Risk Hemoglobinopathies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-11-19","conditions":"Graft Failure, Sickle Cell Disease, Hemoglobinopathies","enrollment":62},{"nctId":"NCT06840756","phase":"PHASE4","title":"Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes","status":"RECRUITING","sponsor":"Michelle Zeller","startDate":"2025-09-11","conditions":"Red Blood Cell Transfusions, Sex Differences, Health Services","enrollment":11082},{"nctId":"NCT07466719","phase":"NA","title":"Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Undergoing Cesarean Section With Major Obstetric Hemorrhage","status":"RECRUITING","sponsor":"Aswan University","startDate":"2025-09-01","conditions":"Obstetric Hemostasis, Intravascular Hemolysis, Major Obstetric Hemorrhage","enrollment":50},{"nctId":"NCT07465029","phase":"","title":"A Study of Incidence, Treatment Patterns, and Outcomes in Transfusion-dependent Lower-risk Myelodysplastic Syndromes in Spain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2026-02-02","conditions":"Lower-risk Myelodysplastic Syndromes (TD LR-MDS)","enrollment":1300},{"nctId":"NCT06499285","phase":"PHASE3","title":"A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-05-06","conditions":"Myelodysplastic Syndromes","enrollment":225},{"nctId":"NCT07190560","phase":"NA","title":"Against Chikungunya Virus and Neonatal Infection","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de la Réunion","startDate":"2026-04-01","conditions":"Chikungunya Virus Infection, Neonatal, Transfusion","enrollment":60},{"nctId":"NCT03587272","phase":"PHASE2","title":"Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease","status":"RECRUITING","sponsor":"Robert Nickel","startDate":"2018-04-17","conditions":"Sickle Cell Disease","enrollment":100},{"nctId":"NCT07459491","phase":"","title":"Agreement Between ChatGPT-5 and Anesthesiologists in Preoperative Risk Assessment: ASA Classification","status":"ACTIVE_NOT_RECRUITING","sponsor":"Damla Kaytancı Özçelik","startDate":"2025-12-02","conditions":"Artifical Intelligence, Preoperative Evaluation","enrollment":703},{"nctId":"NCT07462962","phase":"","title":"Effects of Mindfulness Meditation Training on Anxiety and Sleep Quality of Patients With Hematopoietic Stem Cell Transplantation During Admission in the Laminar Flow Chamber","status":"COMPLETED","sponsor":"Henan University","startDate":"2025-03-01","conditions":"Hematopoietic Stem Cell Transplantation (HSCT), Cancer and / or Hematological Malignancy","enrollment":70},{"nctId":"NCT07422480","phase":"PHASE3","title":"A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions","status":"RECRUITING","sponsor":"Takeda","startDate":"2026-04-01","conditions":"Myelodysplastic Syndrome, Anemia","enrollment":300},{"nctId":"NCT07453368","phase":"PHASE2","title":"Orelabrutinib in the Treatment of Relapsed/Refractory AIHA","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-03-01","conditions":"Autoimmune Hemolytic Anemia (AIHA)","enrollment":50},{"nctId":"NCT07457879","phase":"","title":"Impact of the Reimbursement of Fibrinogen in Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Erasme University Hospital","startDate":"2026-03-20","conditions":"Cardiac Surgery","enrollment":450},{"nctId":"NCT04040023","phase":"NA","title":"Patient Blood Management in Cardiac Surgery","status":"COMPLETED","sponsor":"Clinique Pasteur","startDate":"2019-09-10","conditions":"Surgical Blood Loss","enrollment":900},{"nctId":"NCT05430659","phase":"","title":"Intraoperative Estimated Blood Loss, Blood Transfusion, and Postoperative Clinical Outcomes in Patients Undergoing Non Cardiac Surgery, Siriraj Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Siriraj Hospital","startDate":"2022-07-01","conditions":"General Surgery, Blood Loss, Surgical","enrollment":1268},{"nctId":"NCT00004850","phase":"","title":"Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"1991-03-15","conditions":"Hepatitis C, Hepatitis B","enrollment":805},{"nctId":"NCT05736419","phase":"PHASE2","title":"A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-02-09","conditions":"Sickle Cell Disease, Thalassemia, Beta, Thalassemia","enrollment":24},{"nctId":"NCT03775954","phase":"","title":"Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2018-07-01","conditions":"High Risk Pregnancy, Congenital Heart Disease, Fetal Hydrops","enrollment":30},{"nctId":"NCT06829901","phase":"NA","title":"The Effect of Uterine Entry In Fetoscopic Laser Photocoagulation for Twin-To-Twin Transfusion Syndrome","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2025-03-14","conditions":"Twin to Twin Transfusion","enrollment":216},{"nctId":"NCT05679401","phase":"PHASE3","title":"A Study With Imlifidase in Anti-GBM Disease","status":"TERMINATED","sponsor":"Hansa Biopharma AB","startDate":"2022-12-22","conditions":"Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome","enrollment":50},{"nctId":"NCT04084080","phase":"PHASE3","title":"Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2020-02-26","conditions":"Sickle Cell Disease","enrollment":173},{"nctId":"NCT07446647","phase":"PHASE1","title":"Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion","status":"NOT_YET_RECRUITING","sponsor":"Jose Cancelas","startDate":"2026-03","conditions":"Healthy Volunteer Red Blood Cell Labeling Study; Not Disease Focused","enrollment":20},{"nctId":"NCT05356195","phase":"PHASE3","title":"Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-05-03","conditions":"Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn","enrollment":16},{"nctId":"NCT04770779","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2021-11-30","conditions":"Transfusion-dependent Alpha-Thalassemia, Transfusion-dependent Beta-Thalassemia","enrollment":258},{"nctId":"NCT03692052","phase":"PHASE2","title":"A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2019-03-20","conditions":"Thalassemia","enrollment":20},{"nctId":"NCT07441720","phase":"PHASE2","title":"Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2026-02-28","conditions":"Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia","enrollment":25},{"nctId":"NCT04770753","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2021-12-20","conditions":"Non-Transfusion-dependent Alpha-Thalassemia, Non-Transfusion-dependent Beta-Thalassemia","enrollment":194},{"nctId":"NCT07432737","phase":"NA","title":"One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip Fractures","status":"RECRUITING","sponsor":"University Hospital for Surgical Diseases St. Naum Ohridsk i- Skopje","startDate":"2026-02-17","conditions":"Hip Fractures","enrollment":120},{"nctId":"NCT07437755","phase":"NA","title":"Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cirrhosis Undergoing Invasive Procedures","status":"RECRUITING","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2025-06-01","conditions":"Liver Cirrhosis With Acute Decompensation","enrollment":116},{"nctId":"NCT04171635","phase":"","title":"Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2019-12-16","conditions":"MRI Scans","enrollment":55},{"nctId":"NCT06078696","phase":"PHASE1, PHASE2","title":"Siplizumab for Sickle Cell Disease Transplant","status":"TERMINATED","sponsor":"Columbia University","startDate":"2023-09-28","conditions":"Anemia, Sickle Cell","enrollment":1},{"nctId":"NCT07436767","phase":"NA","title":"Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Sickle Cell Disease","enrollment":3},{"nctId":"NCT06302491","phase":"PHASE2","title":"A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia","status":"RECRUITING","sponsor":"Kind Pharmaceuticals LLC","startDate":"2024-05-27","conditions":"β -Thalassemia","enrollment":64},{"nctId":"NCT07420582","phase":"","title":"Antegrade Autologous Blood Reinfusion After CPB","status":"RECRUITING","sponsor":"Kocaeli City Hospital","startDate":"2026-02-23","conditions":"Coronary Artery Disease","enrollment":130},{"nctId":"NCT06070350","phase":"PHASE3","title":"Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children","status":"RECRUITING","sponsor":"Philip Spinella","startDate":"2024-11-01","conditions":"Hemorrhagic Shock, Trauma Injury","enrollment":1000},{"nctId":"NCT07428265","phase":"NA","title":"Comparison of Wound Healing for Diabetic Carbuncle Treated With Incision and Drainage Technique Using Cruciate Incision vs Saucerization Technique Both Followed by Vacuum Assisted Closure.","status":"RECRUITING","sponsor":"King Edward Medical University","startDate":"2026-01-02","conditions":"Carbuncle","enrollment":124},{"nctId":"NCT06364774","phase":"PHASE1, PHASE2","title":"ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2025-04-14","conditions":"Beta-Thalassemia","enrollment":12},{"nctId":"NCT05647733","phase":"NA","title":"Restrictive Fluid Management In Liver Transplantation (REFIL)","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2023-04-25","conditions":"Liver Transplantation","enrollment":138},{"nctId":"NCT07215975","phase":"","title":"A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2026-02-26","conditions":"β-thalassemia","enrollment":200},{"nctId":"NCT07425600","phase":"","title":"Individualized Dose of Fibrinogen Following Cardiopulmonary Bypass","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2026-03-01","conditions":"Fibrinogen Deficiency in Complex Cardiac Surgery","enrollment":150},{"nctId":"NCT07420296","phase":"PHASE4","title":"Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder","status":"RECRUITING","sponsor":"Tianjin Medical University General Hospital","startDate":"2026-01-01","conditions":"Neuromyelitis Optica Spectrum Disorders (NMOSD)","enrollment":198},{"nctId":"NCT06483334","phase":"PHASE1, PHASE2","title":"A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-17","conditions":"Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma","enrollment":38},{"nctId":"NCT06979492","phase":"PHASE4","title":"Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease","status":"RECRUITING","sponsor":"Emory University","startDate":"2026-04","conditions":"Sickle Cell Disease, Pregnancy Related","enrollment":50},{"nctId":"NCT04356781","phase":"","title":"Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing","status":"COMPLETED","sponsor":"Walton Centre NHS Foundation Trust","startDate":"2020-09-28","conditions":"Multifocal Motor Neuropathy (MMN), Chronic Inflammatory Demyelinating Polyradiculoneuropathy","enrollment":20},{"nctId":"NCT07341139","phase":"","title":"Blood Storage Related Mortality and Adverse Effects in Trauma Patients","status":"RECRUITING","sponsor":"Kocaeli City Hospital","startDate":"2026-01-17","conditions":"Transfusion Adverse Reaction, Major Trauma, Blood Product Transfusion for All Conditions","enrollment":300},{"nctId":"NCT00148629","phase":"PHASE3","title":"Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women","status":"COMPLETED","sponsor":"Cornell University","startDate":"2004-04","conditions":"Anemia, Low Birth Weight, Neonatal Mortality","enrollment":2500},{"nctId":"NCT02201576","phase":"PHASE2","title":"Bortezomib in Rejection of Kidney Transplants","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-02-11","conditions":"Chronic Antibody-mediated Transplant Rejection","enrollment":60},{"nctId":"NCT01220011","phase":"NA","title":"Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-04-19","conditions":"Blood and Blood Disorders, Anemia, Neonatal, Hematologic Disease","enrollment":179},{"nctId":"NCT03657394","phase":"NA","title":"Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nemours Children's Clinic","startDate":"2022-10-17","conditions":"Hypoxic-Ischemic Encephalopathy, Birth Asphyxia","enrollment":3442},{"nctId":"NCT06710418","phase":"NA","title":"Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-10-15","conditions":"Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma","enrollment":50},{"nctId":"NCT04684719","phase":"PHASE3","title":"Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial","status":"COMPLETED","sponsor":"Jason Sperry","startDate":"2022-04-19","conditions":"Hemorrhagic Shock, Traumatic Injury","enrollment":1020},{"nctId":"NCT07328191","phase":"NA","title":"Quality of Life-Guided Transfusion in Refractory MDS or AML","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2026-02-09","conditions":"MDS, AML, Adult, Anemia","enrollment":52},{"nctId":"NCT07157839","phase":"","title":"Phosphorylated Tau Levels in Donated Blood","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-08-28","conditions":"Alzheimer&Amp;#39;s Disease","enrollment":250},{"nctId":"NCT06909487","phase":"","title":"Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respect to HAS 2014 Recommendations","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-03-25","conditions":"Very Preterm and Extremely Preterm Birth, Anemia, Erythrocyte Transfusion","enrollment":201},{"nctId":"NCT04390971","phase":"NA","title":"Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia","status":"COMPLETED","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2023-02-10","conditions":"Transfusion Dependent Beta-Thalassaemia","enrollment":3},{"nctId":"NCT07400341","phase":"PHASE2","title":"Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2026-01-31","conditions":"MDS (Myelodysplastic Syndrome), Aplastic Anemia (AA)","enrollment":66},{"nctId":"NCT07399275","phase":"","title":"Submental Tissue Oxygenation and Arterial Lactate in Major Surgery","status":"NOT_YET_RECRUITING","sponsor":"Bursa Sevket Yilmaz Training and Research Hospital","startDate":"2026-02-15","conditions":"Microcirculatory Dysfunction, Tissue Hypoperfusion, Microcirculatory Status","enrollment":150},{"nctId":"NCT05136794","phase":"","title":"LIdocaine veRsus Sufentanil Anaesthesia in Cardiac Surgery With Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2021-12-01","conditions":"Opioid Free Anaesthesia, Opioid Anaesthesia","enrollment":1772},{"nctId":"NCT07097337","phase":"","title":"Point of Care Fibrinogen Measurement in Trauma Patients in the Emergency Department","status":"RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2025-11-01","conditions":"Trauma Induced Coagulopathy, Trauma Coagulopathy, Fibrinogen Deficiency","enrollment":150},{"nctId":"NCT02741648","phase":"","title":"RBC Irradiation, Anemia and Gut Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2016-07","conditions":"Anemia, Necrotizing Enterocolitis","enrollment":324}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":52787,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Blood transfusion","genericName":"Blood transfusion","companyName":"Medical University of Vienna","companyId":"medical-university-of-vienna","modality":"Biologic","firstApprovalDate":"","aiSummary":"Blood transfusion is the process of transferring blood products into a person's circulation intravenously to replace lost components of the blood. It is commonly used for various medical conditions, including Transfusion Related Complication, Abdominal Aortic Aneurism, Abdominal Aortic Rupture, Perioperative/Postoperative Complications, and Surgical Blood Loss, using interventions such as Red Blood Cell transfusions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":9,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}